Clofarabine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Clofarabine. Educational only — not medical advice.
Labeled uses
Clofarabine Injection is indicated for the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least two prior regimens. This indication is based upon response rate. There are no trials verifying an improvement in disease-related symptoms or increased survival with Clofarabine Injection.
Source: FDA labeling via NIH DailyMed (set fe6ff0f9…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.